CHAPTER 11. Aging-related memory disorders - Alzheimer's Disease.

Bacskai BJ, Kajdasz ST, McLellan ME, Games D, Seubert P, Schenk D,
Hyman BT: "Non-Fc-mediated mechanisms are involved in clearance of
amyloid-beta in vivo by immunotherapy". J Neurosci 2002, 22:7873-7878.

Bales, K.R., Dodart, J.C., DeMattos, R.B., Holtzman, D.M., and Paul,
S.M.: “Apolipoprotein E, Amyloid and Alzheimer’s Disease”. Molecular
Interventions, 2(6):363-375.

Buttini M, Yu GQ, Shockley K, Huang Y, Jones B, Masliah E, Mallory M,
Yeo T, Longo FM, Mucke L: "Modulation of Alzheimer-like synaptic and
cholinergic deficits in transgenic mice by human apolipoprotein E depends
on isoform, aging, and overexpression of amyloid beta peptides but not on
plaque formation". J Neurosci 2002, 22:10539-10548.

Corcoran KA, Lu Y, Turner RS, Maren S: "Overexpression of hAPPswe
impairs rewarded alternation and contextual fear conditioning in a
transgenic mouse model of Alzheimer's disease". Learn Mem 2002,
9:243-252.

D'Arcangelo G, Homayouni R, Keshvara L, Rice DS, Sheldon M, Curran
T: "Reelin is a ligand for lipoprotein receptors". Neuron 1999, 24:471-479.

De Strooper B: "Aph-1, Pen-2, and Nicastrin with Presenilin Generate an
Active gamma-Secretase Complex". Neuron 2003, 38:9-12.

Dickey, C. A., Loring, J. F., Montgomery, J., Gordon, M. N., Eastman, P.
S., and Morgan, D. (2003). Selectively reduced expression of synaptic
plasticity-related genes in amyloid precursor protein + presenilin-1
transgenic mice. J Neurosci 23, 5219-5226.

Grassi F, Palma E, Tonini R, Amici M, Ballivet M, Eusebi F: "Amyloid
beta(1-42) peptide alters the gating of human and mouse alphabungarotoxin-sensitive nicotinic receptors". J Physiol 2003, 547:147-157.

Hock, C., Konietzko, U., Streffer, J. R., Tracy, J., Signorell, A., MullerTillmanns, B., Lemke, U., Henke, K., Moritz, E., Garcia, E., et al. (2003).
Antibodies against beta-amyloid slow cognitive decline in Alzheimer's
disease. Neuron 38, 547-554.

Howe MN, Price IR: "Effects of transdermal nicotine on learning, memory,
verbal fluency, concentration, and general health in a healthy sample at
risk for dementia". Int Psychogeriatr 2001, 13:465-475.

Ibanez-Tallon I, Miwa JM, Wang HL, Adams NC, Crabtree GW, Sine SM,
Heintz N: "Novel modulation of neuronal nicotinic acetylcholine receptors
by association with the endogenous prototoxin lynx1". Neuron 2002,
33:893-903.

Kamenetz F, Tomita T, Hsieh H, Seabrook G, Borchelt D, Iwatsubo T,
Sisodia S, Malinow R: "APP processing and synaptic function". Neuron
2003, 37:925-937.

Lee DH, Wang HY: "Differential physiologic responses of alpha7 nicotinic
acetylcholine receptors to beta-amyloid1-40 and beta-amyloid1-42". J
Neurobiol 2003, 55:25-30.

Levin ED, Bettegowda C, Blosser J, Gordon J: "AR-R17779, and alpha7
nicotinic agonist, improves learning and memory in rats". Behav
Pharmacol 1999, 10:675-680.

Macor JE, Gurley D, Lanthorn T, Loch J, Mack RA, Mullen G, Tran O,
Wright N, Gordon JC: "The 5-HT3 antagonist tropisetron (ICS 205-930) is
a potent and selective alpha7 nicotinic receptor partial agonist". Bioorg
Med Chem Lett 2001, 11:319-321.

Nagele, R. G., D'Andrea, M. R., Anderson, W. J., and Wang, H. Y. (2002).
Intracellular accumulation of beta-amyloid(1-42) in neurons is facilitated by
the alpha 7 nicotinic acetylcholine receptor in Alzheimer's disease.
Neuroscience 110, 199-211.

Nordberg, A., Hellstrom-Lindahl, E., Lee, M., Johnson, M., Mousavi, M.,
Hall, R., Perry, E., Bednar, I., and Court, J. (2002). Chronic nicotine
treatment reduces beta-amyloidosis in the brain of a mouse model of
Alzheimer's disease (APPsw). J Neurochem 81, 655-658.

Phiel, C. J., Wilson, C. A., Lee, V. M., and Klein, P. S. (2003). GSK-3alpha
regulates production of Alzheimer's disease amyloid-beta peptides. Nature
423, 435-439.

Redwine JM, Kosofsky B, Jacobs RE, Games D, Reilly JF, Morrison JH,
Young WG, Bloom FE: "Dentate gyrus volume is reduced before onset of
plaque formation in PDAPP mice: a magnetic resonance microscopy and
stereologic analysis". Proc Natl Acad Sci U S A 2003, 100:1381-1386.

Selkoe DJ: "Alzheimer's disease is a synaptic failure". Science 2002,
298:789-791.

Selkoe DJ, Schenk D: "ALZHEIMER'S DISEASE: Molecular
Understanding Predicts Amyloid-Based Therapeutics". Annu Rev
Pharmacol Toxicol 2003, 43:545-584.

Shaw S, Bencherif M, Marrero MB: "Janus kinase 2, an early target of
alpha 7 nicotinic acetylcholine receptor-mediated neuroprotection against
Abeta-(1-42) amyloid". J Biol Chem 2002, 277:44920-44924.

Stein TD, Johnson JA: "Lack of neurodegeneration in transgenic mice
overexpressing mutant amyloid precursor protein is associated with
increased levels of transthyretin and the activation of cell survival
pathways". J Neurosci 2002, 22:7380-7388.

Vitolo OV, Sant'Angelo A, Costanzo V, Battaglia F, Arancio O, Shelanski
M: "Amyloid beta -peptide inhibition of the PKA/CREB pathway and longterm potentiation: reversibility by drugs that enhance cAMP signaling".
Proc Natl Acad Sci U S A 2002, 99:13217-13221.

Van Uden E, Mallory M, Veinbergs I, Alford M, Rockenstein E, Masliah E:
"Increased extracellular amyloid deposition and neurodegeneration in
human amyloid precursor protein transgenic mice deficient in receptorassociated protein". J Neurosci 2002, 22:9298-9304.

Wang H, Yu M, Ochani M, Amella CA, Tanovic M, Susarla S, Li JH, Yang
H, Ulloa L, Al-Abed Y, Czura CJ, Tracey KJ: "Nicotinic acetylcholine
receptor alpha7 subunit is an essential regulator of inflammation". Nature
2003, 421:384-388.

Williamson, R., Scales, T., Clark, B. R., Gibb, G., Reynolds, C. H., Kellie,
S., Bird, I. N., Varndell, I. M., Sheppard, P. W., Everall, I., and Anderton,
B. H. (2002). Rapid tyrosine phosphorylation of neuronal proteins
including tau and focal adhesion kinase in response to amyloid-beta
peptide exposure: involvement of Src family protein kinases. J Neurosci
22, 10-20.

Winblad, B., and Blum, K. I. (2003). Hints of a therapeutic vaccine for
Alzheimer's? Neuron 38, 517-518.

Wirths O, Multhaup G, Czech C, Blanchard V, Tremp G, Pradier L,
Beyreuther K, Bayer TA: "Reelin in plaques of beta-amyloid precursor
protein and presenilin-1 double-transgenic mice". Neurosci Lett 2001,
316:145-148.

Wood, E. R., and Dudchenko, P. A. (2003). Aging, spatial behavior and
the cognitive map. Nat Neurosci 6, 546-548.